Age-associated increase in salt sensitivity is accompanied by a shift in the atrial natriuretic peptide modulation of the effect of marinobufagenin on renal and vascular sodium pump
暂无分享,去创建一个
[1] S. Haller,et al. Monoclonal antibody against marinobufagenin reverses cardiac fibrosis in rats with chronic renal failure. , 2012, American journal of hypertension.
[2] Erika Salvi,et al. Genes Involved in Vasoconstriction and Vasodilation System Affect Salt-Sensitive Hypertension , 2011, PloS one.
[3] E. Silva,et al. Renal aging in WKY rats: Changes in Na+,K+-ATPase function and oxidative stress , 2010, Experimental Gerontology.
[4] J. Shapiro,et al. Endogenous cardiotonic steroids and salt-sensitive hypertension. , 2010, Biochimica et biophysica acta.
[5] K. Yamagishi,et al. Relationship of urinary cGMP excretion with aging and menopausal status in a general population. , 2009, Journal of atherosclerosis and thrombosis.
[6] O. Fedorova,et al. Endogenous cardiotonic steroids and differential patterns of sodium pump inhibition in NaCl-loaded salt-sensitive and normotensive rats. , 2009, American journal of hypertension.
[7] J. Shapiro,et al. Endogenous Cardiotonic Steroids: Physiology, Pharmacology, and Novel Therapeutic Targets , 2009, Pharmacological Reviews.
[8] E. Lakatta,et al. Monoclonal antibody to an endogenous bufadienolide, marinobufagenin, reverses preeclampsia-induced Na/K-ATPase inhibition and lowers blood pressure in NaCl-sensitive hypertension , 2008, Journal of hypertension.
[9] C. Scavone,et al. Age-related changes in cerebellar phosphatase-1 reduce Na,K-ATPase activity , 2008, Neurobiology of Aging.
[10] David E. Anderson,et al. Endogenous sodium pump inhibitors and age-associated increases in salt sensitivity of blood pressure in normotensives. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.
[11] E. Frohlich,et al. The aging hypertensive heart: a brief update , 2008, Nature Clinical Practice Cardiovascular Medicine.
[12] A. Richards,et al. Natriuretic Peptides: Update on Peptide Release, Bioactivity, and Clinical Use , 2007, Hypertension.
[13] E. Lakatta,et al. ANP Differentially Modulates Marinobufagenin-Induced Sodium Pump Inhibition in Kidney and Aorta , 2006, Hypertension.
[14] N. Maeda,et al. The role of natriuretic peptides in cardioprotection. , 2006, Cardiovascular research.
[15] E. Lakatta,et al. Brain ouabain stimulates peripheral marinobufagenin via angiotensin II signalling in NaCl-loaded Dahl-S rats , 2005, Journal of hypertension.
[16] C. Scavone,et al. Age-related changes in cyclic GMP and PKG-stimulated cerebellar Na,K-ATPase activity , 2005, Neurobiology of Aging.
[17] E. Lakatta,et al. Myocardial PKC &bgr;2 and the Sensitivity of Na/K-ATPase to Marinobufagenin Are Reduced by Cicletanine in Dahl Hypertension , 2003, Hypertension.
[18] E. Lakatta,et al. Marinobufagenin, an endogenous ligand of alpha-1 sodium pump, is a marker of congestive heart failure severity , 2002, Journal of hypertension.
[19] E. Lakatta,et al. Endogenous Ligand of &agr;1 Sodium Pump, Marinobufagenin, Is a Novel Mediator of Sodium Chloride–Dependent Hypertension , 2002, Circulation.
[20] J. Bełtowski,et al. Regulation of renal tubular sodium transport by cardiac natriuretic peptides: two decades of research. , 2002, Medical science monitor : international medical journal of experimental and clinical research.
[21] T. Lue,et al. Age-related decrease of protein kinase G activation in vascular smooth muscle cells. , 2001, Biochemical and biophysical research communications.
[22] P. Greengard,et al. INCREASED BLOOD PRESSURE AND LOSS OF ANP-INDUCED NATRIURESIS IN MICE LACKING DARPP-32 GENE , 2001, Clinical and experimental hypertension.
[23] E. Lakatta,et al. Endogenous Na,K Pump Ligands Are Differentially Regulated During Acute NaCl Loading of Dahl Rats , 2000, Circulation.
[24] C. Bailly. Effect of luminal atrial natriuretic peptide on chloride reabsorption in mouse cortical thick ascending limb: inhibition by endothelin. , 2000, Journal of the American Society of Nephrology : JASN.
[25] Orton,et al. EFFECTS ON BLOOD PRESSURE OF REDUCED DIETARY SODIUM AND THE DIETARY APPROACHES TO STOP HYPERTENSION ( DASH ) DIET , 2000 .
[26] H. Fotis,et al. Phosphorylation of the alpha-subunits of the Na+/K+-ATPase from mammalian kidneys and Xenopus oocytes by cGMP-dependent protein kinase results in stimulation of ATPase activity. , 1999, European journal of biochemistry.
[27] G. Blanco,et al. Isozymes of the Na-K-ATPase: heterogeneity in structure, diversity in function. , 1998, American journal of physiology. Renal physiology.
[28] K. Sweadner,et al. Phosphorylation of Na,K-ATPase by Protein Kinase C at Ser18 Occurs in Intact Cells but Does Not Result in Direct Inhibition of ATP Hydrolysis* , 1997, The Journal of Biological Chemistry.
[29] M. Omata,et al. Elevation of ouabainlike compound levels with hypertonic sodium chloride load in rat plasma and tissues. , 1997, Hypertension.
[30] A. Cowley,et al. Genetic and nongenetic determinants of salt sensitivity and blood pressure. , 1997, The American journal of clinical nutrition.
[31] T. Ogihara,et al. [Bartter syndrome]. , 2020, Nihon rinsho. Japanese journal of clinical medicine.
[32] P. Greengard,et al. Activation/deactivation of renal Na+,K+‐ATPase: a final common pathway for regulation of natriuresis , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[33] C. Frampton,et al. Renal, endocrine, and hemodynamic interactions of atrial and brain natriuretic peptides in normal men. , 1994, The American journal of physiology.
[34] E. Barrett-Connor,et al. Increasing sensitivity of blood pressure to dietary sodium and potassium with increasing age. A population study using casual urine specimens. , 1990, American journal of hypertension.
[35] J. F. Hennessy. Vascular tissue (Na,K)ATPase activity and aging in the F344 rat , 1988, Mechanisms of Ageing and Development.